IPC Digital Health, Uber Health Collaborate on Patient Transport
Pharmaceutical Commerce
OCTOBER 20, 2023
Partnership intends to indirectly boost patient medication adherence rates in the process.
Startup Launches To Support Low-Income Patients with Complex Needs
MedCity News
FEBRUARY 2, 2024
It offers primary and behavioral care for underserved patients. It also provides social care, such as food, housing and transportation assistance. Accompany Health launched Tuesday with $56 million in Series A funding.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
“Patients are only numbers on an Excel spreadsheet”
World of DTC Marketing
DECEMBER 3, 2021
She has decided to leave the pharma industry because she said, “patients have been reduced to numbers on an excel spreadsheet” and “I am tired of trying to get coworkers to see them as people with real needs.” I remember the first time I sat in qualitative research with patients experiencing depression.
Patients 
259
259 
Uber Health Launches Grocery, Over-the-counter Delivery Service for Patients
MedCity News
JUNE 13, 2023
Providers and payers will be able to use Uber Health to deliver healthy groceries and over-the-counter items to patients who need them. They’ll be able to do this on the same platform they use to request non-emergency medical transportation and prescription delivery.
Transportation 100
100 
Making the Case for Case Management for Cell and Gene Therapies
Advertisement
As demand for advanced therapies increases, so does the need for more specialized supply chain support, as these products have strict transportation and handling requirements.
Improving Patient Outcomes with Immersive Learning
Infuse Medical
MAY 2, 2024
In the healthcare Operations field, achieving the best possible patient outcomes is paramount. This means ensuring patients not only understand their diagnosis but are also empowered to participate actively in their treatment plan. It utilizes computer-generated simulations to create realistic and interactive environments.
Patients 52
52 
Uber Health, Socially Determined Strike Partnership
MedCity News
JANUARY 8, 2024
Through a new partnership, payers and providers will be able to leverage Socially Determined’s social risk data to identify which patients have barriers to accessing healthcare and what those barriers are.
Transportation 126
126 
Steps to building a more patient-centric industry
pharmaphorum
DECEMBER 1, 2022
Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.
Patients 98
98 
Why care at home belongs in health equity strategies
MedCity News
OCTOBER 16, 2022
But encountering patients in the context of their home and family puts issues of equity and access into sharp contrast, allowing case managers to connect patients to ongoing resources for SDoH or transportation. Providers can’t treat what they can’t detect.
Transportation 127
127 
Save Someone’s Life in 5 Minutes or Let Them Die in 30?
MedCity News
JULY 3, 2023
Instead of immediately transporting patients, local EMS now work cardiac arrests in the field for 30 minutes; if there’s no change, they call it a “death in the field” because they know they cannot get the patient to a hospital in time for life-saving care.
Transportation 100
100 
Building Patient Trust Through Authentic Imagery in Healthcare Marketing
PM360
AUGUST 24, 2023
Representation Matters for Patient Trust T rust in healthcare is crucial when it comes to improving patient outcomes. It affects everything from acceptance of treatment , adhering to treatment plans, to overall patient satisfaction.
Marketing 98
98 
Cognitive decline in early Alzheimer’s could stem from serotonin loss
PharmaTimes
DECEMBER 18, 2023
MCI patients had 25% lower levels of serotonin compared to healthy patients Researchers from Johns Hopkins Medicine have suggested that serotonin loss in parts of the brain may play a role in cognitive decline in the early stages of Alzheimer’s disease (AD).
How to Modernize Clinical Trials to Promote Enhanced Patient Diversity and Access
PM360
JULY 26, 2023
An initial and discernible benefit to adopting decentralized clinical trial (DCT) models is alleviating patient burden by mitigating unnecessary travel through the utilization of eClinical platforms, mobile phlebotomy/nursing services, local clinics, and other technologies.
Patients 95
95 
CMS Proposes New Services for Vulnerable Patients: Reimbursement for Community Health Integration, Social Determinants Risk Assessment, and Principal Illness Navigation
Nixon Gwilt Law
AUGUST 9, 2023
healthcare system is access to equitable care for our most vulnerable patient populations. Rethinking Healthcare: Addressing Social Determinants in Patient Treatment Practitioners and their staff often dedicate valuable time and resources to understanding the social determinants that may impact their ability to successfully treat a patient.
Patients 89
89 
Improving Transplant Survival with Organ Preservation Tech: Interview with Dr. Anderson, CEO of Paragonix
Medgadget
JULY 12, 2022
Paragonix Technologies , a medtech company based in Massachusetts, created the SherpaPak, an FDA organ transportation device that is intended to keep donor organs safe and viable on their journey to a transplant recipient. The traditional method for organ transport is to simply pack it in ice in a beer cooler and hope for the best.
Putting Patients First: Improving the Pharmaceutical Supply Chain
Impetus Digital
JANUARY 30, 2023
Medications and supplies must be handled with the utmost care, often needing to comply with strict temperature regulations and changing demands from patients and providers that vary depending on the country. Add this to infrastructure challenges like cold storage or delays, and it’s no wonder patient needs are not always put first.
Patient Engagement Strategies for Marketing Success
Healthcare Success
JULY 31, 2023
As a hospital or health system, you know the value of patient engagement. You understand that it’s crucial for improving the overall patient experience and health outcomes for people of all socio-economic classes. But are you up-to-date with the latest patient engagement strategies? What Is Patient Engagement?
Marketing 52
52 
The financial toxicity of treating cancer
World of DTC Marketing
JANUARY 4, 2022
(Stat News) Today, a study followed 380 patients being treated at community oncology groups across the U.S. transportation), and indirect expenses (e.g., Patients who experience financial hardship during cancer treatment are at higher risk for treatment nonadherence, poor quality of life, and worse survival.
Insurance 273
273 
From trial design for patients to trial design with patients: a key topic at DIA ’22
pharmaphorum
JUNE 30, 2022
At the 2022 Drug Information Association (DIA) annual meeting last week, it was inspiring to connect with fellow research and development (R&D) stakeholders, regulators, health and digital data partners and more to navigate challenges in drug development that impact patients globally. Patient journey. Patient access.
Patients 62
62 
Embedding the Patient Point of View in Everything You Do
PM360
SEPTEMBER 15, 2022
The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?
Patients 98
98 
Access solutions: the missing link that prevents biopharma innovation from reaching patients
pharmaphorum
DECEMBER 18, 2022
Science has taken a vertical growth trajectory, yet such innovations are, at best, slow to reach the patients in need. We believe that innovation in patient access models is the necessary catalyst to aid patients in starting on and staying on the therapies they need to improve their lives.
Biopharma 81
81 
Biogen to develop amyloid beta-targeting antibody platform
European Pharmaceutical Review
APRIL 12, 2023
Biogen has exercised the option to license Denali’s Antibody Transport Vehicle (ATV): Amyloid beta program (ATV:Aβ). The antibody transport platform The BBB protects the brain from harmful substances and pathogens circulating in the bloodstream. These include transferrin receptors, which are expressed at the BBB.
Light up the patient journey with self-service analytics
Clarify Health
APRIL 6, 2021
In a full digitized future, biopharmaceutical companies should be able to process and analyze medical disparities and Real-World Evidence data to crystallize patient care journeys across any therapeutic areas – in minutes. However, the reality today is that the industry is just beginning to embark on its technological transformation.
Patients 52
52 
Study: Black Children Less Likely Than White Counterparts to Receive EMS Transportation to Hospital for Asthma Episode
Pharmacy Times
OCTOBER 10, 2023
Investigators hope that continued research and addressing disparities can improve equitable access to asthma treatments for all pediatric patients.
How one pharma “family business” places patients first
pharmaphorum
OCTOBER 26, 2022
And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.
Patients 71
71 
Support bot for cancer patient relatives wins WHO Health Hackathon
pharmaphorum
OCTOBER 27, 2022
The Health Hackathon – which took place in the western city of Lviv in war-torn Ukraine – saw more than 40 teams showcase digital solutions to the challenges faced by patients and doctors, competing for recognition and promise of financial backing to take their projects to the next level. Main image source: WHO.
Patients 52
52 
New partnership to aid supply of Ga-68-based radiopharmaceuticals
European Pharmaceutical Review
APRIL 4, 2024
Positively, RLS noted that the new deal between the two companies will facilitate a steady and reliable supply of Ga-68-based radiopharmaceuticals to be closer to patients. This means Ga-68-based radiopharmaceuticals must “be produced within minutes of patient dosing,” Belcher added.
Meeting global demand for patient independence: SHL Medical expands production in Charleston, US
Pharmaceutical Technology
NOVEMBER 7, 2022
SHL Medical is a world-leading solutions provider for advanced drug delivery systems with a unified purpose to further enable patient independence. Growing demand for patient independence. Consequently, pharmaceutical and biotech companies are increasingly looking to provide devices that allow patients to self-administer drugs.
Medical 52
52 
Lexicon gets FDA approval for Inpefa to treat heart failure
Pharmaceutical Technology
MAY 29, 2023
Inpefa is a once-daily oral tablet indicated as an inhibitor of sodium-glucose co-transporter type 2 (SGLT2) and type 1 (SGLT1). The approval for Inpefa was based on data from two double-blind, placebo-controlled and randomised Phase III cardiovascular outcomes trials in patients with heart failure or who are at risk of heart failure.
GSK requires supplier sustainability compliance from 2023
European Pharmaceutical Review
SEPTEMBER 22, 2022
These strategic requirements enable GSK to align with the global move toward being green, something which the company stated shows its devotion not only to suppliers but patients and pharmaceutical professionals alike, giving them confidence as future customers. In addition, transport suppliers must have green transport solutions.
Transportation 101
101 
Inside One Startup’s Approach to Improving Medicaid Members’ Outcomes and Patient Experience
MedCity News
DECEMBER 13, 2022
Five months later, Emcara is saying that the program is seeing significant engagement and improving patients’ ability to keep up with their care plan. This summer, Adventist Health began a three-year partnership with Emcara Health, a primary care provider group that deploys community health workers into the places people live.
Patients 103
103 
Ipsen concludes purchase of Albireo Pharma
Pharmaceutical Technology
MARCH 3, 2023
Albireo’s pipeline includes its lead asset, Bylvay (odevixibat), a potent, once-a-day, oral, non-systemic, ileal bile acid transport inhibitor (IBATi). In 2021, it secured regulatory approvals in the US to treat pruritus in progressive familial intrahepatic cholestasis (PFIC) in patients aged three months and above.
Pharma 52
52 
The power of patterns: patient journeys, data analytics and the quest for a better healthcare system
Clarify Health
JANUARY 2, 2024
Leveraging Data to Improve Patient Journeys Healthcare Unbound episode recap: There’s never been more healthcare data (or access to it). Data on various aspects of patients’ journeys through the healthcare system are particularly powerful for both providers and payers. “But they have evolved over time.”
Healthcare 52
52 
Delivery systems for biologics
European Pharmaceutical Review
MARCH 4, 2024
Therefore, biologics identification and characterisation poses unparalleled challenges, as does their manufacturing processes and routes of administration while maintaining patient safety and clinical efficacy. Notably, LNPs facilitate the transportation of large payloads, have limited immunogenicity, and allow for scalable manufacturing.
Gilead plans $4.3 billion deal to advance liver portfolio
European Pharmaceutical Review
FEBRUARY 14, 2024
Clinical studies have demonstrated its potential in regulating genes involved in bile acid synthesis, inflammation, fibrosis and lipid metabolism, storage, and transport. percent for patients on seladelpar versus 20.0 percent for patients on seladelpar versus 0.0
ZyVersa Therapeutics inches closer to European patent approval for VAR 200
Pharmaceutical Technology
JUNE 7, 2023
The Phase IIa-ready VAR 200 is being developed to reduce renal cholesterol and the lipid accumulation that damages the filtration system of kidneys in glomerular diseases patients. The application was filed for the treatment of diabetic nephropathy/diabetic kidney disease. VAR 200 works by removing the extra lipids from the kidney.
Addressing Socioeconomic Barriers in Myelofibrosis Care
Pharmacy Times
JANUARY 24, 2024
Shawn Griffin, PharmD, reviews strategies to tackle socioeconomic challenges in myelofibrosis treatment, covering costs, transportation, language barriers, cultural sensitivity, and patient communication.
Fireside Chat with Anthony Capone, President & CTO of DocGo
Impetus Digital
OCTOBER 5, 2022
Anthony Capone President & CTO Anthony Capone is the president and CTO of DocGo where he has helped to build one of the largest providers of last-mile mobile health services and integrated medical transportation solutions in the US. Register now! Register for this free webinar. Book a Consultative Demo.
When it comes to telehealth it’s not numbers
World of DTC Marketing
FEBRUARY 18, 2022
Still, they are more likely to continue use because of complex medical conditions or a nonclinical factor such as lack of transportation” OK, so where to start…First, let’s ask a fundamental question “why are people using telehealth? 83% believed the quality of the patient-physician communication was good.
Doctors 247
247 
Your Patients Want Holistic Care — Here’s How Data Helps You Treat the Whole Person
Salesforce
SEPTEMBER 16, 2022
Two patients with the same diagnosis, prescribed the same medical regime, and treated by the same doctor in the same hospital could have wildly different outcomes. Examining your patients’ health within the context of their lives is critical. Examining your patients’ health within the context of their lives is critical.
Patients 52
52 
Leading pharmaceutical logistics and pharma supply chain companies
Pharmaceutical Technology
SEPTEMBER 6, 2022
The pharmaceutical supply chain is a global and complex network that includes a wide range of stakeholders such as pharmaceutical manufacturers, wholesale distributors, and pharmacy benefit managers (PBM), to ensure efficient and timely delivery of medications to the patients.
Meeting rising demands of a new radiotheranostic era
European Pharmaceutical Review
AUGUST 31, 2023
Cancer patients critically depend on accurate diagnosis and disease treatment. By reaching cancer cells that have already spread throughout the body, a targeted radiopharmaceutical treatment offers an alternative for patients with advanced cancer when standard lines of treatment, such as chemotherapy, have failed.
FDA approves Ipsen’s Bylvay for cholestatic pruritus due to ALGS
Pharmaceutical Technology
JUNE 14, 2023
Ipsen has received US Food and Drug Administration (FDA) approval for Bylvay (odevixibat) to treat patients aged 12 months and above with cholestatic pruritus caused by Alagille syndrome (ALGS). More than 90% of patients who received treatment with odevixibat were pruritus responders.
Rare Disease Day 2024: Advocating for Awareness and Support
PM360
FEBRUARY 12, 2024
Created by The European Organization for Rare Diseases (EURORDIS) , this globally coordinated event brings together industry stakeholders to advocate for increased access to medical treatment for patients, caregivers, and their families.
Let's personalize your content